ICU Medical COO settles PRSUs, nets 6,552 shares

ICU Medical Chief Operating Officer Christian B. Voigtlander reported compensation-related share activity tied to performance awards.

Rhea-AI Filing Summary

ICU Medical Chief Operating Officer Christian B. Voigtlander reported compensation-related share activity tied to performance awards. He exercised performance-based restricted stock units and restricted stock units that settled into 14,648 shares of Common Stock, with no purchase or exercise price.

These units were granted on 3/15/2023 and, after the Compensation Committee certified results on 2/11/26, the performance-based awards were earned at 117% of target. To cover tax obligations, 8,096 shares were withheld at $125.85 per share, leaving a net increase of 6,552 shares. Following these transactions, Voigtlander directly owns 46,306 shares of Common Stock.

Insider Trade Summary

14,648 shares exercised/converted

Exercise 6 txns

Insider Voigtlander Christian B.

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Common Stock	3,248	$0.00	$0.00
Exercise	Performance Shares	11,400	$0.00	$0.00
Exercise	Common Stock	11,400	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	6,301	$125.85	$793K
Exercise	Common Stock	3,248	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,795	$125.85	$226K

Holdings After Transaction: Common Stock — 0 contracts (Direct); Performance Shares — 0 contracts (Direct); Common Stock — 46,306 shares (Direct)

Footnotes (5)

1. F1. These Securities are Performance-based Restricted Stock Units (PRSU).
2. F2. Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.
3. F3. These securities are Restricted Stock Units.
4. F4. There is neither a purchase price nor an exercise price for the Restricted Stock Units.
5. F5. There is neither a purchase price nor an exercise price for the PRSUs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ICU Medical (ICUI) COO Christian Voigtlander report on this Form 4?

He reported the settlement of performance-based and time-based stock units into 14,648 shares of Common Stock. The activity reflects equity compensation vesting, not open-market buying or selling, with some shares withheld for taxes.

How many ICU Medical (ICUI) shares did the COO receive from PRSUs and RSUs?

He acquired 14,648 shares of Common Stock through the exercise and settlement of performance-based restricted stock units and restricted stock units. These equity awards converted into shares at no purchase or exercise price to him.

Were the ICU Medical (ICUI) COO’s Form 4 transactions open-market sales?

No, the disposition entries reflect tax withholding, not market sales. A total of 8,096 shares of Common Stock were withheld at $125.85 per share to satisfy tax obligations on the vested equity awards.

What performance result triggered the ICU Medical (ICUI) PRSU settlement?

Performance stock units granted on 3/15/2023 were earned at 117% of target. This followed certification of performance results by the Compensation Committee on 2/11/26, leading to the acquisition of the reported shares.

How many ICU Medical (ICUI) shares does the COO own after these transactions?

After the equity awards settled and tax withholding occurred, Christian Voigtlander directly owns 46,306 shares of Common Stock. This figure reflects his post-transaction holdings reported in the Form 4 filing.

What types of equity awards were involved in the ICU Medical (ICUI) Form 4?

The filing involves Performance-based Restricted Stock Units (PRSUs) and Restricted Stock Units (RSUs). Both have no purchase or exercise price, and upon vesting they settle into shares of ICU Medical common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Voigtlander Christian B.

(Last) (First) (Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE CA 92673

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/15/2026		M		11,400(2)	A	$0.0	51,154	D
Common Stock	03/15/2026		F		6,301	D	$125.85	44,853	D
Common Stock(3)	03/15/2026		M		3,248	A	$0.0	48,101	D
Common Stock	03/15/2026		F		1,795	D	$125.85	46,306	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock(3)	$0.0(4)	03/15/2026		M			3,248	03/15/2026	03/15/2026	Common Stock	3,248	$0.0	0	D
Performance Shares(1)	$0.0(5)	03/15/2026		M			11,400(2)	03/15/2026	03/15/2026	Common Stock	11,400	$0.0	0	D

Explanation of Responses:

1. These Securities are Performance-based Restricted Stock Units (PRSU).

2. Represents the settlement of performance stock units granted on 3/15/2023. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 117% of target, resulting in the acquisition of the shares reported herein.

3. These securities are Restricted Stock Units.

4. There is neither a purchase price nor an exercise price for the Restricted Stock Units.

5. There is neither a purchase price nor an exercise price for the PRSUs.

	By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.